At the end of their cycle, hematocrit concentrations experienced greater by 3%-position in contrast with baseline. The increase was not linked to for a longer time use or greater AAS dose. A reason behind this may very well be that, further than a certain degree of androgenic activity, no more boost of hematocrit occurs: a ‘ceiling influence’. … Read More